2. Disclaimer: This presentation contains forward-looking statements
relating to the business outlook, operating and financial projections, and
the growth prospects of Tempo Participações S.A.
These statements merely represent projections and as such are based
exclusively on Management’s expectations about the future of the
business.
Such forward-looking statements depend substantially on changes in
market conditions, the performance of the Brazilian economy, the
industry and international markets, and therefore are subject to change
without prior notice.
2
4. Highlights
New Assistance Contracts: Tempo signed news contracts with Minas Brasil (Zurich Group) and Banco
do Brasil;
Stock Buyback Program: In 1Q09, Tempo purchased 2,6MM TEMP3 shares representing a R$7,5MM
investment;
EBITDA: Posted a solid growth of 10,7% QoQ, reaching R$18MM;
EBITDA Margin: Increase of 1,1 p.p. QoQ at 10,4% margin.
4
6. Health Segment
Beneficiaries (in Millions)
Soft growth of 2,2% in the Health
Segment´s beneficiaries base.
Net Revenues (in R$Million)
Higher medical utilization by our clients had
a positive impact in net revenues.
6
7. Health Segment
Cost of Rendered Services (in R$Million) SG&A Expenses (in R$Million)
EBITDA (in R$Million)
Higher medical utilization by Gama Saúde
Clients (worsened ebitda margin)
Processes internalization in Gama Saúde to
improve its service level
Efectiva increase in loss ratio driven by
integration & investments to improve the7
service provided
9. Dental Segment
Net Revenues (in R$Million)
The Dental Segment in the 1Q09 grew
68,4% QoQ, showing significant gains
directly correlated with its growing
beneficiary base.
9
10. Dental Segment
Cost of Rendered Services (in R$Million)
Through M&A activity, Tempo changed
its Dental business model, impacting its
loss ratio profile
Dental loss ratio track record
10
11. Dental Segment
Selling, General & Administrative Expenses (in R$Million)
SG&A had a determinant impact driven
by M&A activity in 2008.
SME clients and Affinity channel demand
higher investments in brokerage fee and
commissions
EBITDA (in R$Million)
Increase of 22,9% in the Dental
Segment´s EBITDA reaching R$5,0MM.
Ebitda margin impacted by SG&A
expenses
11
12. Assistance Segment
Items (in Millions)
Assistance 1Q09 impacted by Bradesco
contract termination.
Net Revenues (in R$Millions)
Accounting changes translates in a
increase in Net Revenues
12
13. Assistance Segment
Costs of Rendered Services (in R$Million)
Accounting changes translates in a
increase in cost of rendered services
Assistance Loss Ration Curve adjusted to accounting changes
13
14. Assistance Segment
Selling, General & Administrative Expenses (in R$Million)
Strong improvement in SG&A margin
boosted by efficiency processes (5p.p.
margin improvement).
EBITDA (in R$Million)
Robust growth in EBITDA, posting
25.3% growth over the same period in
2008, despite the reduction in top-line.
14
15. CAPEX
CAPEX
Tempo ended 1Q09 with CAPEX at R$1,9 Million representing 10,6%
of Adjusted EBITDA.
15
